-
Turning SAP Feedback into HTA-Ready Action: A Semi-Automated Approach for RWD Studies
Sep 9, 2025, 16:22 PM -
Estimating the Mean Time in Treatment-Free Remission for Patients in Early Line CML
Sep 9, 2025, 16:22 PM -
Health Economic Assessment of Cefepime-Enmetazobactam for Treating Complicated Urinary Tract Infections: A German Payer Perspective
Sep 9, 2025, 16:22 PM -
Why Are Patient-Reported Outcome Measure (PROM) Results Missing From Labels of Obesity Management Medications?
Sep 9, 2025, 16:22 PM -
Economic Burden of Progressive Pulmonary Fibrosis (PPF) in the Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Primary Expenditure Drivers and Future Challenges From Emerging Technologies in Brazilian Private Market Real-World Data Analysis From a Brazilian Employer-Sponsored, Self-Insured Health Plan
Sep 9, 2025, 16:22 PM -
A Comparison of the NICE HST Program With Health Technology Assessments of Ultra-Orphan Drugs From France and Germany
Sep 9, 2025, 16:22 PM -
Integrating Equity and Efficiency in Health Economic Evaluation: Development of Equity-Informed Methodologies in the French Healthcare Context (INEES Project)
Sep 9, 2025, 16:22 PM -
Fair Pricing of Innovative Medicines From Definition to Application in CAR-T Cell Therapy
Sep 9, 2025, 16:22 PM -
Real-World Treatment Patterns Among Patients Newly Diagnosed With Chronic Inflammatory Demyelinating Polyneuropathy in the United States
Sep 9, 2025, 16:22 PM -
Bimekizumab Demonstrated Sustained Long-Term Improvements in Health-Related Quality of Life and Work Productivity in Patients With Active Psoriatic Arthritis: 3-Year Results from Two Phase 3 Studies
Sep 9, 2025, 16:22 PM -
Characteristics and Treatment of Prevalent Heart Failure in the US: A Cross-Sectional Analysis of Annual Trends From 2014-2023
Sep 9, 2025, 16:22 PM -
Malnutrition-Related Healthcare Costs in Hospitalized IBD Patients: A Nationwide Real-World Data Analysis in Italy
Sep 9, 2025, 16:22 PM -
When Less Is More? Learnings From a Recent NICE Submission Utilizing a Novel Predictive Individual-Level Surrogacy Approach to Predict Overall Survival (OS) in the Absence of Trial-Level Evidence
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization Associated With Acute Pancreatitis in Patients With Familial Chylomicronemia Syndrome Treated With Olezarsen: A Post Hoc Analysis of Balance Study Data
Sep 9, 2025, 16:22 PM -
Mapping to EQ-5D Utility in Knee Osteoarthritis: A Comparative Evaluation of WOMAC and SF-36 Algorithms in the STEP 9 Trial
Sep 9, 2025, 16:22 PM -
Treatment Patterns in Epithelial Ovarian Cancer (EOC) With a Focus on Recurrent EOC and PARPi Progressors: A Targeted Literature Review Across Selected Countries
Sep 9, 2025, 16:22 PM -
Systematic Literature Review on the Burden and Economic Impact of Invasive Meningococcal Disease in Adolescents and Young Adults in the UK
Sep 9, 2025, 16:22 PM -
Development of a Partitioned Survival Model Template for Oncology Indications: A Flexible and Customizable Framework
Sep 9, 2025, 16:22 PM -
What Drives European Union (EU) Health Technology Assessment (HTA) Decisions in Melanoma? A Targeted Review on Clinical Evidence Critiques
Sep 9, 2025, 16:22 PM
